Airsupra™ (albuterol/budesonide) – New drug approval
January 11, 2023 - The FDA announced the approval of AstraZeneca’s Airsupra (albuterol/budesonide), for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.
Top